Fundamental Steps Along the Path Toward the Treatment of Disease
CHORI Scientist Solves Crystal Structure of Iron Regulatory Protein Complex
In an exciting new development in the field of mRNA research, CHORI Senior Scientist Elizabeth C. Theil, PhD and her colleagues have elucidated the structure of iron regulatory protein 1 (IRP1) complexed to the mRNA structure that regulates ferritin synthesis, iron responsive element (IRE).
"On a personal level, I've been tracking down this three-dimensional structure since about 1981," says Dr. Theil.
Dr. Theil had studied the RNA structure with ordinary and exotic chemical nucleases, mutagenesis, nuclear magnetic resonance spectroscopy, and all the tools of molecular and chemical biology and biochemistry, often in collaboration with William Walden, PhD, who is an expert with IRP1 - all to no avail.
"Getting the crystals of either the structured RNA with the binding protein, as we were just able to do," explains Dr. Theil, "required the magic of a three-way collaboration with x-ray crystallographer. Karl Volz.
A dual functioning protein, IRP1 is both an RNA binding protein, as it is found in the crystal structure in this study, as well as catalytic protein, when it binds an iron-sulfur cluster to become to a metabolic enzyme called aconitase. Understanding the structure of the IRE-RNA/IRP1 complex could reveal important clues toward the identification of potential drug targets for diseases caused by the mis-regulation of iron.
"The main reason I was interested in this structure," says Dr. Theil, "was because I wanted to know how the RNA looked when protein-bound and what changes occurred in the RNA and the protein when they bound."
While scientists have always known that all RNAs, including the ferritin IRE, had both "rigid" and "floppy" parts in solution alone, the only information scientists had about its bound structure was which parts of the RNA were covered up by the protein, not how they fit together.
While the study represents a landmark in basic research, identifying the structural elements of the IRE-RNA/IRP1 complex is also a significant milestone in the future development of disease treatments.
"Knowing the structure of the mRNA when it's bound to the protein means we have a target with which to manipulate the regulation of iron," explains Dr. Theil. "Even when people have too much iron in their bodies, there is still a lot of mRNA bound with protein that can't be translated. If we could find a small molecule that would knock of that protein, displace it some how, those mRNAs could make a lot more ferritin, which in turn, would synthesize the excess iron."
Such an approach could eventually transform the treatment of patients with thalassemia and sickle cell disease who suffer from iron overload as a byproduct of live-saving blood transfusions. Yet the study has myriad implications beyond iron regulatory diseases alone.
As Dr. Theil explains, "How this information relates to iron regulation specifically is very important, but if you think about it broadly, it can be applicable in all areas of disease in which the body makes too much of this or too little of that - and that's almost every disease. The real issue is finding out more about mRNA and how to manipulate it."
Of course, targeting mRNA instead of DNA is a whole new approach and, like any other scientific revolution, such as the development of antibiotics or cancer therapies, developing it will take a long, concerted effort and the continued scientific illumination that fundamental basic research studies as this one provide.Back
Monday, May 16, 2011 11:33 PM